Mysthera Therapeutics

Switzerland
Breíl, Grisons, Switzerland, 4052

Company profile

Mysthera Therapeutics company profile

Mysthera Therapeutics is a pharmaceutical company Mysthera plans to reshape the treatment landscape for autoimmune disease. PIM kinase inhibition uniquely and selectively modulates immune cell function in multiple lineages associated with complex disease.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2023-01-01, Year

Headquarters

Postal code
4052
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$3.5M
Last funding
Seed / $3.5M / 2023-08-21
Last equity funding
Seed / $3.5M
Investors
1
Lead investors
1
Articles
3

Founders and investors

Lead investors

Forty51 Ventures

Investors

Forty51 Ventures